Depression and anxiety

Medical Journal of Australia

Volumn 1, Issue , 2012, Pages 28-32

  Tiller, John W G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

AGITATION; ANXIETY; ARTICLE; BLURRED VISION; COGNITION; DEPRESSION; DIARRHEA; DIZZINESS; DYSPNEA; EMOTION; FATIGUE; FLUSHING; HEADACHE; HEALTH CARE UTILIZATION; HEART PALPITATION; HUMAN; HYPERVENTILATION; MICTURITION DISORDER; MYALGIA; NAUSEA AND VOMITING; RESTLESSNESS; TACHYCARDIA; THORAX PAIN; VERTIGO; XEROSTOMIA;

EID: 84905800402     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mjao12.10628     Document Type: Article

References (48)

1. Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: summary of results, 2007. Canberra: ABS, 2007. (ABS Cat. No. 4326.0.) http://www.abs.gov.au/ausstats/abs@.nsf/mf/4326.0 (accessed Sep 2012).
2. Hunt C, Issakidis C, Andrews G. DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well- Being. Psychol Med 2002; 32: 649-659.
3. Gorman JM. Comorbid depression and anxiety spectrum disorders. Depress Anxiety 1996-1997; 4: 160-168.
4. Pollack MH. Comorbid anxiety and depression. J Clin Psychiatry 2005; 66 Suppl 8: 22-29.
5. Gonçalves DC, Pachana NA, Byrne GJ. Prevalence and correlates of generalized anxiety disorder among older adults in the Australian National Survey of Mental Health and Well-Being. J Affect Disord 2011; 132: 223-230.
6. Regier DA, Rae DS, Narrow WE, et al. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry Suppl 1998; (34): 24-28.
7. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-627.
8. Sartorius N, Ustün TB, Lecrubier Y, Wittchen HU. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl 1996; (30): 38-43.
9. Jameson JP, Blank MB. Diagnosis and treatment of depression and anxiety in rural and nonrural primary care: national survey results. Psychiatr Serv 2010; 61: 624-627.
10. Goldberg D. Epidemiology of mental disorders in primary care settings. Epidemiol Rev 1995; 17: 182-190.
11. Wittchen HU, Kessler RC, Pfister H, Lieb M. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand Suppl 2000; (406): 14-23.
12. Middeldorp CM, Cath DC, Van Dyck R, Boomsma DI. The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies. Psychol Med 2005; 35: 611-624.
13. Boyer P. Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl 2000; (406): 24-29.
14. Maes M, Kubera M, Obuchowiczwa E, et al. Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 2011; 32: 7-24.
15. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry 2000; 157: 1243-1251.
16. Kuzel RJ. Treating comorbid depression and anxiety. J Fam Pract 1996; 43 (6 Suppl): S45-S53.
17. Brown C, Schulberg HC, Madonia MJ, et al. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996; 153: 1293-1300.
18. Andersson D, Magnusson H, Carstensen J, Borgquist L. Co-morbidity and health care utilisation five years prior to diagnosis for depression. A register-based study in a Swedish population. BMC Public Health 2011; 11: 552.
19. Katon W, Unützer J, Russo J. Major depression: the importance of clinical characteristics and treatment response to prognosis. Depress Anxiety 2010; 27: 19-26.
20. McIntyre RS, Liauw S, Taylor VH. Depression in the workforce: the intermediary effect of medical comorbidity. J Affect Disord 2011; 128 Suppl 1: S29-S36.
21. Coryell W, Fiedorowicz JG, Solomon D, et al. Effects of anxiety on the long-term course of depressive disorders. Br J Psychiatry 2012; 200: 210-215.
22. Andrews G, Sanderson K, Slade T, Issakidis C. Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment. Bull World Health Organ 2000; 78: 446-454.
23. Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. Br J Psychiatry 2001; 178: 145-153.
24. Cepoiu M, McCusker J, Cole MG, et al. Recognition of depression by non-psychiatric physicians – a systematic literature review and meta-analysis. J Gen Intern Med 2008; 23: 25-36.
25. Sheehan DV, Lecruibier Y. MINI Mini International Neuropsychiatric Interview. English version 5.0.0. 2006. http://www.nccpsychiatry.info/File/MINI500.pdf (accessed Sep 2012).
26. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 2002; 32: 959-976.
27. Zigmond AS, Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
28. Hickie IB, Davenport TA, Hadzi-Pavlovic D, et al. Development of a simple screening tool for common mental disorders in general practice. Med J Aust 2001; 175 (2 Suppl): S10-S17.
29. Guy W. ECDEU assessment manual for psychopharmacology. Revised, 1976. Rockville, Md: National Institute of Mental Health, 1976.
30. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 2008; 165: 342-351.
31. Australian Government Department of Health and Ageing. Better access to psychiatrists, psychologists and general practitioners through the MBS (Better Access) initiative. http://www.health.gov.au/mentalhealth-betteraccess (accessed Sep 2012).
32. Quidé Y, Witteveen AB, El-Hage W, et al. Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: a systematic review. Neurosci Biobehav Rev 2012; 36: 626-644.
33. Fava GA, Ruini C, Rafanelli C, et al. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 2004; 161: 1872-1876.
34. Tiller JWG. Cognitive behaviour therapy in medical practice. Aust Prescr 2001; 24: 33-37. http://www.australianprescriber.com/magazine/24/2/33/7 (accessed Sep 2012).
35. Cuijpers P, Clignet F, van Meijel B, et al. Psychological treatment of depression in inpatients: a systematic review and meta-analysis. Clin Psychol Rev 2011; 31: 353-360.
36. Rizzo M, Creed F, Goldberg D, et al. A systematic review of non-pharmacological treatments for depression in people with chronic physical health problems. J Psychosom Res 2011; 71: 18-27.
37. Oestergaard S, Møldrup C. Improving outcomes for patients with depression by enhancing antidepressant therapy with non-pharmacological interventions: a systematic review of reviews. Public Health 2011; 125: 357-367.
38. Casey MF, Perera DN, Clarke DM. Psychosocial treatment approaches to difficult-to-treat depression. MJA Open 2012; 1 Suppl 4: 52-55.
39. Andrews G, Creamer M, Crino R, et al, editors. The treatment of anxiety disorders: clinician guides and patient manuals. 2nd ed. Cambridge: Cambridge University Press, 2003.
40. Kyrios M, Mouding R, Nedeljkovic M. Anxiety disorders – assessment and management in general practice. Aust Fam Physician 2011; 40: 370-374.
41. Gonçalves DC, Byrne GJ. Interventions for generalized anxiety disorder in older adults: systematic review and meta-analysis. J Anxiety Disord 2012; 26: 1-11.
42. Therapeutic Guidelines Limited. eTG complete. 2012. http://www.tg.org.au/ index.php?sectionid=71 (accessed Sep 2012).
43. Chan HN, Mitchell PB, Loo CKA, Harvey SB. Pharmacological treatment approaches to difficult-to-treat depression. MJA Open 2012; 1 Suppl 4: 44-47.
44. Harrison C, Britt H, Charles J. Antidepressant use. Aust Fam Physician 2011; 40: 365.
45. Keks NA, Burrows G D, Copolov DL, et al. Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression? Med J Aust 2007; 186: 142-144.
46. Monteleone P, Martiadis V, Maj M. Circadian rhythms and treatment implications in depression. Prog Neuropsychopharmac ol Biol Psychiatry 2011; 35: 1569-1574.
47. Berk M, Berk L, Davey CG, et al. Treatment of bipolar depression. MJA Open 2012; 1 Suppl 4: 32-35.
48. Vulink NCC, Figee M, Denys D. Review of atypical antipsychotics in anxiety. Eur Neuropsychopharmacol 2011; 21: 429-449.